Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the empa-heart trial

HIGHLIGHTS

• who: Lorenzo Nesti from the of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy have published the paper: Effect of empagliflozin on left ventricular contractility and peak oxygen uptake in subjects with type 2 diabetes without heart disease: results of the EMPA-HEART trial, in the Journal: (JOURNAL) of 21/08/2022
• what: Baseline characteristics of the study population According to inclusion and exclusion criteria, 106 consecutive patients were screened for the study from December 2017 to July 2020; after baseline evaluation, 37 were subsequently excluded because of definitive exclusion criteria and 13 did . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.